Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

PepsiCo (NQ: PEP )

148.34 +0.17 (+0.11%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about PepsiCo

< Previous 1 2
...
29 30 31 32 33 34 35 36 37
...
87 88 Next >
Are People Done Buying Chips And Soda? Stock Market Winners And Losers From Rise Of Ozempic, Weight-Loss Drugs
With health and wellness becoming increasingly popular in the United States, it’s no surprise that weight-loss drugs like Ozempic and Wegovy have gone viral on TikTok and other social platf 
Via Benzinga
The 7 Best Forever Stocks To Buy Now: October 2023
These best forever stocks have consistently grown their cash flows even in uncertain times and are category leaders set for dominance. 
Via InvestorPlace
7 Dividend Aristocrats to Batten Down the Hatches
With uncertainty clouding the capital market ecosystem, investors may take confidence with these dividend aristocrats. 
Via InvestorPlace
7 Dividend Aristocrats That Are Built to Last
For dependability and durability, take a closer look at these seven dividend stocks, all of which hold aristocratic status. 
Via InvestorPlace
Check Out What Whales Are Doing With PEP
Via Benzinga
Coca-Cola Stock: Buy, Sell, or Hold?
The global leader in non-alcoholic beverages is on a good path to decades more of success. 
Via The Motley Fool
(PEP) - Analyzing PepsiCo's Short Interest
Via Benzinga
1 Growth Stock Down 16% to Buy Right Now
This energy drink company's past and projected growth reverses the stock's pullbacks pretty quickly. 
Via The Motley Fool
How Consumer Goods Will Survive the Negative Impacts of Ozempic
Ozempic is a popular drug doctors are prescribing to millions of patients to fight obesity and diabetes. CNBC reports that in the first six months of 2023 alone, Ozempic sales have grown by 58%. 
Via Talk Markets
3 Stocks to Buy for the Next 25 Years
Finding stocks to buy for the next 25 years isn’t easy. There’s no crystal ball to predict which companies are the most sustainable. 
Via InvestorPlace
Coca-Cola Dives Deeper Into Alcohol: Absolut Vodka Meets Sprite - A Stock Boost Ahead Of Earnings?
Beverage giant Coca-Cola (NYSE: KO) is one of several beverage and food stocks that have been hit due to potential concerns from weight loss drugs h 
Via Benzinga
3 Passive Income Stocks to Hold for the Next 20 Years
Stability is the name of the game, and these stocks deliver in spades. 
Via The Motley Fool
Looking For Passive Income? This Dividend Portfolio Will Pay You Monthly
Via Benzinga
Dividend Income Update September 2023
With the start of the final quarter of 2023, it’s time to take a look back at my previous month of dividend income. 
Via Talk Markets
Is the Ozempic-Driven DexCom Selloff Overdone?
Has glucose monitor maker DexCom corrected too much on fears of lost sales due to weight loss and diabetes drugs made by Novo Nordisk and Eli Lilly? 
Via MarketBeat
Consumer Staples Find Support, Signal Opportunity
The Consumer Staples Select Sector SPDR ETF (XLP) is approaching a crucial support level, potentially signaling a rebound opportunity for investors 
Via MarketBeat
Topics ETFs
These 2 High-Growth Stocks Could Power the Bull Market's Next Record Run
You need new growth stocks to fuel the next market rally. These two stocks have roughly doubled over the past year. 
Via The Motley Fool
Food and Beverage Stocks Look Appetizing After Ozempic Selloff
Investors should brush off Ozempic selloff fears and dive into tasty food and beverage stocks that have been oversold in 2023. 
Via InvestorPlace
Snack Maker Mondelez Int'l Is Down but Not Out
If Mondelez beats consensus for Q3 and can offer reassurance about the potential impact of Ozempic, investors’ appetite for chewed up snack makers may improve. 
Via MarketBeat
McCormick: A Leading Spice And Seasoning Maker With A Solid Dividend
Founded in 1889, McCormick is now a global leader in flavor by manufacturing, marketing, and distributing spices, seasoning mixes, condiments, and other flavorful products to food retailers. The... 
Via Talk Markets
Retire Early with These 7 Millionaire-Maker Growth Stocks
if you want to enjoy passive income and an early retirement, invest in these must-have growth stocks for your retirement portfolio. 
Via InvestorPlace
Topics Retirement
Exposures Pension
Are Ozempic and Similar Treatments Impacting Food and Beverage Stocks? Here's What Pepsi's CFO Said About It
PepsiCo's Q3 earnings may have shed some light on the long-standing speculation about Ozempic's impact on consumer staples. 
Via The Motley Fool
MarketBeat Week in Review – 10/9 - 10/13
Stocks remained under pressure this week as investors wrestled with higher inflation being fueled by surging oil prices and what that means for their portfolio 
Via MarketBeat
Topics Economy
Exposures Economy Interest Rates
7 Dividend Kings to Buy for Royal Returns
These dividend kings earn consistent income from steadily growing payments. Buy these stocks that have risen for 50 years or more. 
Via InvestorPlace
Stable But Split
Is the economy falling off a cliff, headed for a slow landing, or just getting ready to take off is a question that every investor is looking for an answer to these days. 
Via Talk Markets
Topics Economy
Exposures Economy
3 Stocks You Can Keep Forever
Here are three businesses with strong competitive moats and increasing dividend payments that you can park safely in your portfolio forever. 
Via The Motley Fool
3 Stocks Warren Buffett Refuses to Let Go Of
The buy-and-hold investment strategy is on full display with these Warren Buffett stocks that he has owned for over a decade or more. 
Via InvestorPlace
Will Higher Ozempic Use Mean Slimmed-Down Food Sales?
Novo Nordisk's Ozempic, a weight loss drug, is making waves in the food industry, raising concerns about its effect on sales of calorie-laden products. 
Via MarketBeat
Buy Low, Sell High: 7 Blue-Chip Stocks to Snatch Up
Investors should take advantage of the recent market turmoil to buy these rock-solid blue-chip stocks at distressed prices. 
Via InvestorPlace
PepsiCo Shines Amid Volatility: Analyst Consensus Points To Solid Earnings But Volume Growth Concerns Linger
Beverage giant PepsiCo Inc (NASDAQ: PEP) reported third-quarter FY23 results yesterday, with sales growth of 6.7% year-on-year to $23.45 billion, beating the analyst consensus of $23.43 billion. 
Via Benzinga
< Previous 1 2
...
29 30 31 32 33 34 35 36 37
...
87 88 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.